Almost all of my ADXS is split among a Roth IRA, a regular IRA and a 401(k). Very frustrating take-down today. The smoking gun showing how it was pure manipulation was during the part of the day when ADXS was actually down more than ADRO after ADXS announced great trial data and ADRO announced a clinical hold. I thought our first BP deal would end the manipulation, but (Amgen deal) it hasn't. When does is end? Hopefully, solid combo data will take us back to the $20s. I also wonder if we will see a deal soon with Astra on either US/Europe licensing for cervical cancer or global AXAL combo licensing or both.
News 
Market Data 
Discover 
